The first oral anti postpartum depression drug has been approved by the FDA and can take effect within two weeks
August 5, 2023- The US Food and Drug Administration (FDA) approved Zurzuvae (Zuranolone), which is the first oral medication used to treat adult postpartum depression (PPD).